NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Chou R, McDonagh MS, Nakamoto E, et al. Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct. (Comparative Effectiveness Reviews, No. 38.)
Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review [Internet].
Show details- ACR
American College of Rheumatology
- ADAPT
Alzheimer’s Disease Anti-Inflammatory Prevention Trial
- AE
Adverse event
- AHRQ
Agency for Healthcare Research and Quality
- ALT
Alanine aminotransferase
- AMI
Acute myocardial infarction
- AMSTAR
Assessment of Multiple Systematic Reviews
- APC
Adenoma Prevention with Celecoxib trial
- ARAMIS
Arthritis, Rheumatism, and Aging Medical Information System
- ARR
Adjusted relative risk
- AST
Aspartate aminotransferase
- CCOHTA
Canadian Coordinating Office for Health Technology Assessment
- CDME
Central Diabetic Macular Edema trial
- CER
Comparative effectiveness review
- CHD
Coronary heart disease
- CHF
Congestive heart failure
- CI
Confidence interval
- CLASS
Celecoxib Long-term Arthritis Safety Study
- CNS
Central nervous system
- COX
Cyclooxygenase
- CV
Cardiovascular
- DMSO
Dimethyl sulphoxide
- EPC
Evidence-based Practice Center
- FDA
Food and Drug Administration
- GI
Gastrointestinal
- GAIT
Glucosamine/chondroitin Arthritis Intervention Trial
- H2
Histamine 2
- HR
Hazard ratio
- HTN
Hypertension
- INR
Immediate release
- JAMA
Journal of the American Medical Association
- JSM
Joint space measurement
- JSN
Joint space narrowing
- JSW
Joint space width
- MeSH
Medical Subject Headings
- MI
Myocardial infarction
- MUCOSA
Misoprostol Ulcer Complications Outcomes Safety Assessment Trial
- NIH
National Institutes of Health
- NNT
Number needed to treat
- NR
Not reported
- NRS LBP
Numerical rating scale for low back pain
- NS
Not significant
- NSAID
Nonsteroidal anti-inflammatory drug
- OA
Osteoarthritis
- OR
Odds ratio
- OMERACT-OARSI
Outcomes Measures in Arthritis Clinical Trials-Osteoarthritis Research Society International
- PCT
Placebo-controlled trial
- PICOTS
Populations, Interventions, Comparators, Outcomes, Timing and Setting
- POBs
Gastric or duodenal perforation, gastric outlet obstruction, or upper gastrointestinal bleeding
- PPI
Proton pump inhibitor
- PreSAP
Prevention of colorectal sporadic adenomatous polyps
- PUBs
Perforations, symptomatic gastroduodenal ulcers, and upper GI bleeding
- PUD
Peptic ulcer disease
- qd
Once a day (quaque die)
- RA
Rheumatoid arthritis
- RCT
Randomized controlled trial
- RMDQ
Roland Morris Disability Questionnaire
- RR
Relative risk
- RRR
Relative risk reduction
- SCHIP
State Children s Health Insurance
- SF-36
Medical Outcomes Short Form-36
- SMD
Standardized mean difference
- SR
Sustained release
- SR
Rystematic review
- SUCCESS-1
Successive Celecoxib Efficacy and Safety Study-1
- TARGET
Therapeutic Arthritis Research and Gastrointestinal Event Trial
- TEP
Technical Expert Panel
- tid
Three times a day (ter in die)
- UGIB
Upper gastrointestinal bleeding
- UK GPRD
United Kingdom General Practice Research Database
- VAS
Visual analog scale
- VIGOR
Vioxx Gastrointestinal Outcomes Research
- WOMAC
Western Ontario and McMaster Universities Osteoarthritis Index
- Acronyms and Abbreviations - Analgesics for OsteoarthritisAcronyms and Abbreviations - Analgesics for Osteoarthritis
Your browsing activity is empty.
Activity recording is turned off.
See more...